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food webs, farm food webs, forestry 
food webs, orchard food webs or 
motorway embankment food webs, 
despite the fact that these habitats 
can be extensive and are much more 
intimately connected to humans than 
natural habitats.”
“A major problem lies in the extent 
to which constituent species are often 
‘lumped’ into functional groups —  
each bird lovingly identified, while 
individual arachnid species become 
one unitary ‘spiders’ in ways which 
can bias or cloud analyses,” says May.
“Our general quest for 
 understanding how the 
world works, and what 
is our place in it, is the 
 quintessential characteristic 
that sets humanity apart from 
other animals. But better 
understanding of ecosystem 
assembly and collapse is 
arguably of unparalleled 
practical importance for 
ourselves and other living 
things, as humanity’s 
 unsustainable impacts on the 
planet continue to increase.”
Dobson and his colleagues make a 
more general plea for food web theory 
to be widely considered in plans for 
the management of national parks and 
the biodiversity they seek to preserve. 
“A considerable urgency drives 
attempts to assemble data from large 
undisturbed and pristine ecosystems 
such as tropical grasslands, forests and 
coral reefs.” If the principal arguments 
for conserving natural ecosystems are 
based purely on economic benefits 
then we need to develop a theory that 
links ecosystem services to food web 
structure, they say.
“Our general quest for understanding 
how the world works, and what is 
our place in it, is the quintessential 
characteristic that sets humanity 
apart from other animals. But better 
understanding of ecosystem assembly 
and collapse is arguably of unparalleled 
practical importance for ourselves 
and other living things, as humanity’s 
unsustainable impacts on the planet 
continue to increase,” says May.Edward A. Kravitz
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What turned you on to biology 
in the first place? I always was 
interested in science without actually 
knowing much about it. I grew up in 
the North East Bronx and attended 
ordinary city schools, where being 
smart was not necessarily appreciated. 
I graduated high school barely making 
the school ‘honour roll’ acquiring 
about a ‘B’ average, and did not do 
much better at the City College of New 
York, where mostly I was interested 
in girls and basketball. I did get a few 
‘A’ grades. One was in basketball and 
another in Physical Chemistry, the 
hardest course at CCNY, and the only 
one I found interesting. My son once 
looked at my college academic record 
and said “Dad, I am amazed that you 
ever got anyplace in the world”. 
It was my work at Sloan Kettering 
Hospital as a technician for George 
Tarnowski, immediately after 
graduating college, that really turned 
Q & A me on to a career in biochemistry. There, I worked in a cancer 
chemotherapy laboratory injecting 
mice with compound after compound 
in an attempt to stop the growth of 
implanted solid tumours. It wasn’t this 
work that turned me on though; that 
came via a different route. A small 
laboratory adjoined the one I worked 
in, where a young investigator (Louis 
Kaplan) was examining the biochemical 
properties of Ehrlich Ascites tumour 
cells. Lou was the shortstop on the 
Sloan-Kettering softball team and he 
encouraged me to join the team, where 
I ended up as the third baseman. 
Through our association, I started 
asking Lou about his research and as 
a result got interested in the possibility 
that I too might start doing ‘research’ 
on the biochemistry of tumour cells. 
Tarnowski said that would be fine after 
my chores were completed and the 
head of the tumour biology section 
agreed, so I started doing ‘research’. 
Once started, I was hooked. What 
excitement! That led to an evening 
course in biochemistry at CCNY and 
applications for graduate study at 
Rutgers University and the University 
of Michigan, the alma maters of 
scientists in my section at Sloan 
Kettering. Both accepted me; I chose 
the latter, ending up in a very old-
fashioned biochemistry department 
that was in transition.
Do you have a favourite paper? In 
my desk drawer at home, I used to 
keep a copy of Alexander Fleming’s 
1929 paper reporting the discovery 
of penicillin: ‘On the antibacterial 
action of cultures of a penicillium, with 
special reference to their use in the 
isolation of B. influenzæ’ (Br. J. Exp. 
Pathol. 10, 226–36). What I most liked 
about the paper was that something 
that had surely been seen and tossed 
away innumerable times before — a 
mould-contaminated bacterial culture 
plate — yielded an immense find to an 
observant investigator, a discovery that 
has saved countless lives worldwide. 
What Fleming did was pay attention to 
a bacteria-free clear area surrounding 
the mould. In essence, he followed 
the timeless advice of Yogi Berra, the 
former catcher and manager of the 
New York Yankees: “you can observe 
a lot by just watching”. While Fleming 
apparently wasn’t a good enough 
chemist to complete the purification 
of ‘penicillin’ (a name he coined for 
a clear sterile filtrate of the broth of 
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chemical properties, showed that 
it was far better than any existing 
antibacterial agent, demonstrated that 
it was relatively non-toxic, and possibly 
most dramatically, showed that it could 
be topically and effectively applied to 
bandages.
What is the best advice you’ve been 
given, and what advice would you 
offer? Two things come to mind. One 
is the sage advice of my mentor, Steve 
Kuffler, who passed away at the young 
age of 67 in October of 1980. Steve 
always said “the good old days are 
now”. The message is clear. Do not 
live in the past, live in the present and 
enjoy and take full advantage of the 
opportunities now available to you. To 
someone just starting in Biology, my 
advice always is “in making important 
career decisions do not rely solely 
on analysis and logic”. The heart 
should play as important a part in 
your decision making as the head. 
Is this truly a place you want to be? 
Are you selecting your next position 
based on the ranking of individuals or 
institutions, or is the choice you are 
making truly where you want to be?
When I first visited Harvard Medical 
School to look at a possible academic 
position there, my biochemical 
colleagues gave me a list of ‘criteria’ 
that should be satisfied before I should 
consider accepting any position. 
Steve Kuffler and his group — Dave 
Hubel, Torsten Wiesel, Ed Furshpan 
and Dave Potter — had just moved 
to HMS from Johns Hopkins to start 
a Neurophysiology Laboratory in the 
Department of Pharmacology. My 
biochemist colleagues had never 
heard of any of these people and I 
was warned it would end my career 
as a biochemist if I ended up in a 
Pharmacology Department. Their list 
included a position in Biochemistry 
(not Pharmacology), so much start up 
money, so much space, an assistant 
professorship, and so on. Before 
the visit to HMS, I looked up the 
publications of members of the group 
and did not understand anything I 
read. Instead there were squiggly 
lines, incomprehensible abbreviations 
(EPSPs, IPSPs..), and in Steve’s 
papers, cartoons of Steve sticking 
electrodes into cat brains. I was sure 
I was wasting my time in this, my first 
‘job’ interview.
There was little communication 
during my chats with members of the laboratory either — I distinctly 
remember Hubel and Wiesel glancing 
sideways at each other and shuddering 
when I said I was interested in the 
biochemistry of memory. Then came 
the time with Steve. He dismissed 
everything on my list. Instead he 
offered me five years of research 
support in a shared research space in 
Pharmacology, and the opportunity to 
see if I was any good in science. As 
I headed back to Washington on the 
train from Boston, I had an important 
decision to make: would I accept this 
offer? Logic dictated ‘no’. But here 
were people who really seemed to 
know things about the nervous system, 
and here was an opportunity to see if I 
could make it on my own as a scientist 
unhindered by the need to find funding 
for my research and involved in only 
limited teaching to medical students. I 
believe I made the correct choice.
What has been your biggest 
mistake in research? I wouldn’t 
necessarily call it a mistake, but an 
early experiment I carried out never 
was submitted for publication. As a 
beginning graduate student I became 
interested in DNA biosynthesis (still 
a mystery in the mid-1950s). One 
of the experiments I attempted 
aimed to identify intermediates in 
DNA biosynthesis by adding tracer 
amounts of radioactive guanine to 
logarithmically growing Escherichia 
coli. Samples were withdrawn at 
regular times after addition of the 
radioactive material and, after 
centrifugation and acid extraction of 
the cells, these were separated using 
standard methods of the day into 
acid soluble, RNA and DNA fractions. 
Not surprisingly, what I found was 
radioactivity appearing first in the acid 
soluble, then in the RNA and finally in 
the DNA pools. What surprised me, 
though, was that the counts in the RNA 
fraction rose to a peak and then were 
reduced by about 10% after which 
they remained relatively constant. In 
the literature of the day, the gospel was 
that once synthesized, radioactivity 
incorporated into RNA remained 
stable. The advice I received from my 
advisors was, therefore, there is an 
error in your protocol — don’t publish! 
So I didn’t. 
Two years later, Astrachan and 
Volkin did a similar experiment with 
bacteriophage-infected E. coli and 
discovered what they called ‘DNA-like 
RNA’. They also did not quite recognize what they had in their hands, and never 
did get as much recognition as they 
deserved for the discovery of what 
turned out to be messenger RNA. Still, 
had I published, it probably would have 
been a nice first paper for a graduate 
student. On the other hand, I might 
not have gone on with my career in 
neuroscience had I entered the world 
of the molecular biologists with my first 
publication, and that truly would have 
been a mistake and a great shame. 
Mostly I tell this story when I advise 
students not to always listen to their 
advisors — instead, stick to your guns 
if you feel you truly can defend your 
territory.
Do you have a scientific hero? 
Yes, Seymour Benzer, who died last 
year at the age of 86. Seymour was 
a wonderful person and a superb 
scientist. I first met Seymour when he 
was a ‘student’ in the summer Training 
Program in Neurophysiology at the 
Marine Biological Laboratory in Woods 
Hole that was nominally run by Steve 
Kuffler, but was organized and taught 
by Ed Furshpan and Dave Potter. I took 
an immediate liking to Seymour and 
watched in wonder as he wrote, in a 
miniature script in small notebooks, 
notes of any and all possible facts 
extracted from the days conversations. 
Seymour had a way of asking the 
penetrating questions that went to the 
heart of all issues and seemed willing 
to listen to and learn from all comers.
I remember that on one visit to 
our department, I told Seymour that 
lobsters transfer sperm to females 
during mating via spermatophores 
(small sacks containing sperm) that 
the females could hold for up to a 
year before using them to fertilize their 
eggs. I also mentioned that these could 
be released from male lobsters via 
electrical stimulation. I have no idea 
why we were discussing this topic, 
but Seymour insisted that we go to 
the laboratory that instant to attempt 
to release a spermatophore from a 
male lobster. I actually had never done 
this before but, with an AC power 
supply and a rheostat, we turned 
the voltage higher and higher and to 
Seymour’s and my delight, out popped 
a spermatophore. To my surprise, he 
immediately asked for a microscope 
slide and coverslip and rushed us to 
a nearby microscope to tear open the 
spermatophore to release and examine 
the sperm (what else would any 
reasonable person do...).
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Willem Wijnstekers, secretary-general 
of Cites. “Many people derive a 
substantial living from fishing for 
them, while others are involved in 
the aquaculture which grows the fish 
to marketable size. All this is under 
threat unless fishing for European eels 
is put on a more sustainable footing.”
Older eels are caught for their 
meat but glass eels, an early stage 
of eel newly returning to Europe, are 
mostly harvested live to be grown 
to marketable size in aquaculture 
facilities predominantly in Asia, 
but also in Europe. About half the 
eels caught in Europe are exported 
to China, Japan and South Korea 
for this purpose and, in recent 
years, this amounted to more than 
200 million eels per year, Cites says.
Unofficial estimates suggest that, 
as recently as the 1990s, around 
30,000 tons of eels were captured 
every year, with a value of around 
200 million euros and that around 
Slippery issue
This spring, the member countries 
of the Convention on International 
Trade in Endangered Species (Cites) 
have started to regulate trade in the 
European eel, a highly prized delicacy 
in Europe and Asia, given the 
plummeting numbers of this species.
It is widely distributed in coastal 
areas and freshwater ecosystems 
in Europe and the Mediterranean 
and was once abundant. It has one 
of the most complex life histories of 
any vertebrate: adults migrate from 
Europe to the Sargasso Sea near the 
Caribbean where they breed and then 
die. The offspring then rely on ocean 
currents to carry them back to Europe 
where they enter the freshwater river 
systems to grow before setting back 
out for the Sargasso Sea. 
“Eels are no longer the familiar 
sight in European and Caribbean 
waters that they once were,” says 
Steep decline: Numbers of European eels are falling dramatically. (Photo: Alamy/David 
Hosking.)What is your greatest research 
ambition? I want to ‘watch’ behaviour 
happening in the nervous system 
of an intact or semi-intact fruit fly. 
This will require instrumentation 
that will allow us to record optically 
from brain neurons with previously 
defined functions. We will soon have 
available many of the cell lines needed 
to perform these experiments. Many 
technical hurdles remain before the 
experiments actually can be carried 
out — not the least of which is 
obtaining access to the required two-
photon imaging system — but it still 
amazes me that, by switching to fruit 
flies, we now can actually think about 
performing experiments that were only 
dreamed of such a short time ago. 
What do you think are the big 
questions to be answered next 
in your field? Behaviour happens in 
stereotypical patterns which switch 
from one to the other along statistically 
determinable lines. Even though 
we can recognize and score these 
patterns and they are recognizable and 
meaningful to other members of the 
species, each time an animal shows 
a pattern of behaviour, it is different. 
We know and continue to learn a 
great deal about how the ‘wiring 
diagrams’ of nervous systems are 
assembled — clearly transcriptional 
codes are key elements in that 
assembly. But the wiring diagrams 
only represent the scaffolding on 
which behaviour is constructed. 
Much less is known about how 
the scaffolding is assembled into 
simple pattern generating circuits, 
although elegant work from Michael 
Bate’s laboratory at the University 
of Cambridge is beginning to make 
major contributions in that arena. 
Still less is known about how these 
simple patterns are assembled into the 
complex behavioural patterns noted 
by observers of animal behaviour. I 
anticipate that the next decades will 
see major advances in this arena too, 
as investigators begin to address 
questions of how behaviour gets 
wired into nervous systems — what 
are the roles of genes? hormones? 
experience? Once the patterning 
machinery is established, a next key 
step will be, how does behaviour work 
and how is it molded by experience.
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